Ontario public health measures
COVID-19 Info | Information sur la COVID-19 | COVID-19 Vaccine Vaccine Receipt | COVID-19 Self-Assessment
🔍 Search
  • Follow us:
Sign In FR

Middlesex-London Health Unit

🔍Search
🔍
Home
Inner Nav

Influenza for Healthcare Providers

The following list of resources will assist healthcare providers during the influenza season. Please note: This web page is updated with the latest documents and links on a regular basis.

2022-2023 UIIP Vaccine Chart (PDF)

*High-dose QIV vaccine for seniors is no longer available. TIV-Adj. can still be ordered for individuals 65 years of age and older and standard dose QIV is still readily available. Delaying influenza vaccination to wait for a specific product is not recommended. It is very important that seniors receive their seasonal influenza vaccine as soon as possible.

Public Health Ordering System (PHOS): All healthcare providers who order vaccines must use the online Public Health Ordering System (PHOS). To register for PHOS, please have your organization's primary contact complete the online registration form. Orders placed via fax or email are no longer being processed.

 

 
  • Front page of the Influenza Surveillance ReportsInfluenza Surveillance Reports
    The Middlesex London Health Unit’s Influenza Surveillance Report is published weekly during the influenza season. The purpose of the influenza surveillance report is to provide a picture of influenza activity in Middlesex London.
 

Statement on Seasonal Influenza Vaccine

  • The Canadian recommendations for Influenza vaccine are stated by the National Advisory Committee on Immunization (NACI) each year. Provinces take this information into consideration when implementing their own recommendations. 

Co-Administration of Vaccines with the COVID-19 Vaccines

For individuals 5 years of age and older, NACI recommends that COVID-19 vaccines may be administered concomitantly with, or at any time before or after, non-COVID-19 vaccines, including live, non-live, adjuvanted, or unadjuvanted vaccines. For individuals 6 months to under 5 years of age, NACI recommends a wait period of 14 days between COVID-19 vaccine and other vaccine products. Learn more →


2022-2023 Universal Influenza Immunization Program Implementation Package


Components of 2022-2023 Influenza Vaccine

The World Health Organization recommends which components should be included in influenza vaccines each year. For the 2021-2022 influenza season, in the Northern Hemisphere, these will be:

Egg-based QIVs (FluLaval Tetra, FLUZONE Quadrivalent ®, Afluria Tetra® , FLUZONE High-Dose Quadrivalent®)

  • An A/Victoria/2570/2019 (H1N1) pdm09-like virus;
  • An A/Darwin/9/2021 (H3N2)-like virus;
  • A B/Austria/1359417/2021 (B/Victoria lineage)-like virus;
  • A B/Phuket/3073/2013 (B/Yamagata lineage)- like virus

Egg-based TIVs (Fluad®)

  • An A/Victoria/2570/2019 (H1N1) pdm09-like virus;
  • An A/Darwin/9/2021 (H3N2)-like virus;
  • A B/Austria/1359417/2021 (B/Victoria lineage)-like virus;

Influenza Vaccine Product Monographs


Seasonal Influenza Vaccine Consent Form 


Influenza Immunization Reporting Forms

For the 2021-2022 Universal Influenza Immunization Program, the Ministry of Health no longer requires vaccine utilization reports from facilities that participate.

Reporting Requirements for Health Care Worker Influenza Immunization (Long-Term Care Homes and Public Hospitals)

  • Long-term care homes and publicly hospitals are required to report health care worker immunization rates to the Health Unit by mid to late January 2023. Further details regarding collection of health care worker coverage rates, including forms, will be provided when available.

Reporting Requirements for Long-Term Care Home Resident Influenza Immunization

  • Long-term care homes are required to report resident immunization rates to the Health Unit by mid to late January 2023. Further details regarding collection of resident coverage rates, including forms, will be provided when available. 

Influenza Outbreak Tools

Line Lists

Specimen Collection and Testing

Antivirals


Surveillance

Local Surveillance

Provincial Surveillance

National Surveillance


Resources


COVID-19 Pandemic Considerations

The COVID-19 pandemic creates a series of challenges for the delivery of the seasonal influenza immunization program. The following resources have been developed by NACI to address these challenges in various health care settings. 

For additional guidance and setting specific resources, including others on immunization, visit COVID-19 Guidance and Resources for Health Care Providers and Institutions.

 
Date of creation: October 2, 2013
Last modified on: January 9, 2023